• Self-Paced, Online Courses
Course DescriptionIn this talk, Kaitlin Morrison, PhD discussing what an administrative letter is and when an administrative
  • 1.00 Participation
  • Self-Paced, Online Courses
Course DescriptionIn this talk, targeted at the CPO regulatory team, Kaitlin Morrison, PhD talks through how INDs are maintained at LCCC and the respons
  • 1.00 Participation
  • Self-Paced, Online Courses
Course DescriptionClaire Dees, MD, talks with Jared Weiss, MD and Carey Anders, MD, about their early experiences in running
  • 1.00 Participation
  • Self-Paced, Online Courses
  • Investigator Initiated Trials
Course DescriptionIn this talk Mike Matamoros, MS, CIP and Cassie Myers, CIP take you through IRB regulations about investigational assays, using COVID-
  • 1.00 Participation
  • Self-Paced, Online Courses
  • Investigator Initiated Trials
Course DescriptionKaitlin Morrison, PhD takes you through the business principles of critical paths, PERT charts and Gantt charts and how they can be us
  • 1.00 Participation
  • Self-Paced, Online Courses
Course DescriptionKaitlin Morrison, PhD takes you through when a correlative assay is considered an FDA regulated device and what types of devices requi
  • 1.00 Participation
  • Non-Credit Course
  • Advanced Practice Provider
Psycho-oncology or psychosocial oncology is a sub-specialty of oncology that addresses the psychological, behavioral, emotional, and social issues that arise for cancer patie
  • 1.00 Participation
  • Non-Credit Course
  • Advanced Practice Provider
Webinar DescriptionBrian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targete
  • 1.00 Participation
  • Non-Credit Course
  • Patient Centered Care
Testicular cancer is the most common cancer in young men.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicul
  • 1.00 Participation

Pages